gsk
3 stories tagged "gsk"
Investigations
GSK Bankrolled the Study That Turned Its Shingles Vaccine Into a Dementia Headline
The academics who best isolated a shingles-vaccine effect on dementia used a natural experiment and no industry money. The study behind this month's headlines used a claims database and GlaxoSmithKline's checkbook.
InvestigationsA DC judge dismissed the Study 329 suit. The court did not say the paper is honest.
A DC court dismissed an attempt to force JAACAP and Elsevier to retract Study 329. The ruling did not find the paper sound. It found that no reader has standing to make a journal stop selling a fraudulent article.
Brain & AgingThe Shingles Vaccine Keeps Cutting Dementia Risk. The Reason May Not Be the Shingles.
Four big studies now tie the shingles vaccine to lower dementia risk. The most useful finding is that the same effect shows up with an RSV vaccine that shares its adjuvant.